Regulatory Freeze Under the New Trump Administration: Implications for DSCSA Compliance

The Drug Supply Chain Security Act (DSCSA) compliance deadlines are fast approaching. Despite the political landscape’s recent shifts, these deadlines remain firmly in place. The regulatory freeze introduced by the Trump administration in January 2025 has generated discussions, but it does not alter these legally mandated timelines. Businesses must continue their preparations to ensure compliance.

Continue reading Regulatory Freeze Under the New Trump Administration: Implications for DSCSA Compliance

Countdown to May 27th: Manufacturers & Repackagers Prepare for DSCSA

The clock is ticking for pharmaceutical manufacturers and repackagers. By May 27, 2025, they must comply with the Drug Supply Chain Security Act (DSCSA) requirements, a crucial step toward achieving transparency, safety, and accountability within the U.S. drug supply chain. This deadline marks a critical step in creating an interoperable electronic system to track and trace prescription drugs throughout their lifecycle. For those in the pharmaceutical supply chain, the time to act is now.

Continue reading Countdown to May 27th: Manufacturers & Repackagers Prepare for DSCSA